Uses, Side Effects, Price of EUREPA V 0.5/0.3mg Tablet 10's:

EUREPA V 0.5/0.3MG TABLET is a mixture of Repaglinide and Voglibose which belongs to the institution of drug treatments known as Anti-diabetic agents. EUREPA V 0.5/0.3MG TABLET is used as an adjunct (to weight loss plan and workout) to deal with kind 2 Diabetes Mellitus in sufferers to assist manage blood sugar stage.

EUREPA V 0.5/0.3MG TABLET isn't always advocated to be used in sufferers allergic to Repaglinide and/or Voglibose. It is likewise now no longer advocated to be used in sufferers with kind 1 diabetes, diabetic ketoacidosis (severe hardship of diabetes), intense infection (before/after an operation), gastrointestinal obstruction (bowel obstruction) and/or slight to intense liver disease.

Before taking EUREPA V 0.5/0.3MG TABLET, tell your medical doctor in case you are scheduled for a chief surgical treatment and/or have intense illness, fever, trauma, infection, continual intestinal disease, kidney problems (together with mild/slight/intense renal impairment).

EUREPA V 0.5/0.3MG TABLET is normally now no longer advocated to be used at some point of being pregnant and in girls making plans for being pregnant. It is likewise now no longer advocated to be used in breastfeeding girls.

USE EUREPA V 0.5/0.3mg Tablet 10's

• Adjunct to weight loss plan and workout to deal with kind-2 diabetes mellitus in affected individuals

SIDE EFFECTS OF EUREPA V 0.5/0.3mg Tablet 10's:

Most facet consequences now no longer require any clinical interest and disappear as your frame adjusts to the medicine. Consult your physician in the event that they persist or if you’re involved approximately them

• Signs of hypoglycaemia (low blood sugar) together with fast coronary heart rate, shaking, sweating
• Abdominal ache/discomfort, diarrhoea
• Signs of gastritis (irritation of stomach) together with top stomach ache, nausea, vomiting
• Swelling of face/arms/legs
• Headache, fever
• Sore throat

Caution :

• Keep out of reach of children.
• Keep away from direct sunlight.

FAQs:

Q1.What is EUREPA V 0.5/0.3MG TABLET used for? EUREPA V 0.5/0.3MG TABLET is a mixture of Repaglinide and Voglibose which belongs to the institution of drug treatments known as Anti-diabetic agents. It is normally used as an adjunct (to weight loss plan and workout) to deal with kind 2 Diabetes Mellitus in sufferers to assist manage blood sugar stage.

Q2.What are the aspect results of EUREPA V 0.5/0.3MG TABLET? The maximum not unusualplace aspect results of taking EUREPA V 0.5/0.3MG TABLET are hypoglycaemia (low blood sugar), stomach ache/discomfort, diarrhoea, headache, fever, muscle ache and/or tenderness. Consult and tell your medical doctor if any of those signs and symptoms worsen.

Q3. How EUREPA V 0.5/0.3MG TABLET works? EUREPA V 0.5/0.3MG TABLET is a mixture of Repaglinide and Voglibose wherein Repaglinide will increase the quantity of insulin launched with the aid of using the pancreas and Voglibose inhibits the movement of α-glucosidase (an intestinal enzyme answerable for breaking down complicated sugars into easy sugars) which ends up in decreasing the blood glucose stage and hence treating kind-2 diabetes mellitus in affected individuals.